English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
Danaher Q4 Revenues Rise 21 Percent
2022-01-28
Danaher reported on Thursday a 21 percent year-over-year increase in total sales for the fourth quarter, beating the consensus Wall Street estimate. For the three months ended Dec. 31, conglomerate posted $8.15 billion in total sales compared to $6.76 billion in the year-ago period. The analysts' average estimate was $7.92 billion.
iHealth Signed Orders for COVID-19 Reagents, With the Total Amount Increased to About USD 1.275 billion
2022-01-28
iHealth announced that it was disclosed in the previous announcement that the U.S. subsidiary of the company and the ACC of U.S. signed a purchase contract on ihealth coronavirus antigen home self-test OTC kit products on behalf of HHS, purchasing a total of 250 million iHealth kit products.
VIEW has been indexed in Chemical Abstracts Service (CAS) and INSPEC
2022-01-27
VIEW has been indexed in Chemical Abstracts Service (CAS) and Information Service for the Physics, Electro-technology, Computer and Control (INSPEC).
Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent
2022-01-27
Abbott reported Wednesday morning that its fourth quarter diagnostics revenues rose 3 percent year over year, largely as a result of rapid COVID-19 testing.
GE Healthcare's revenue hit by continued supply chain challenges
2022-01-27
GE's healthcare systems organic revenues in the fourth quarter declined 5%, more than offsetting 2% organic growth in pharmaceutical diagnostics. Nonetheless, Culp told investors that healthcare order demand remained strong in the quarter despite supply chain disruptions.
J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report
2022-01-27
Johnson & Johnson on Tuesday projected that its Covid vaccine would generate $3 billion to $3.5 billion in sales in 2022, after posting a mixed fourth-quarter report that slightly beat on earnings estimates but missed on revenue.
Chance of “Pathogenic” Genetic Variant Causing Disease Is Relatively Low
2022-01-26
Imagine getting a positive result on a genetic test. The doctor tells you that you have a “pathogenic genetic variant,” or a DNA sequence that is known to raise the chances for getting a disease like breast cancer or diabetes.
Metagenomi Raises $175M in Series B Financing Round
2022-01-26
Gene editing company Metagenomi said on Tuesday that it has raised $175 million in a Series B financing round, bringing the total funding for the Emeryville, California-based startup to $300 million.
Medcaptain completes acquisition of Penlon, strengthening its position as a perioperative solutions provider
2022-01-26
Shenzhen, China, January 24, 2022: Medcaptain Medical Technology and Penlon, a world-renowned medical device manufacturer, formally entered into an acquisition.
Novogene: Net Profit in 2021 is Expected to Increase by 419.99%-523.99% year-on-year
2022-01-25
Recently, Novogene released the finance forecast that the net profit attributable to owners of the parent company in 2021 was 190 million to 228 million yuan, a year-on-year increase of 419.99% to 523.99%.
Illumina, National Cancer Center Japan Collaborate on Nasopharyngeal Cancer Study
2022-01-25
Illumina said on Monday that it is collaborating with National Cancer Center Japan on a study of nasopharyngeal carcinoma.
Mutations Behind the Omicron Variant’s High Rate of Infection Identified
2022-01-25
While the Omicron variant continues to infect people around the world, researchers at the University of Missouri have identified the highly prevalent, specific mutations that are causing the Omicron variant’s high rate of infection.
The Metabolic Interactions That Make Pancreatic Tumor Cells Grow
2022-01-24
Pancreatic cancer is a rare, yet elusive and deadly cancer, with a five-year survival rate of about 10%. If the cancer has metastasized, that rate lowers to 3%. And treatment options are extremely limited.
Prolight Diagnostics to Acquire UK Point-of-Care Firm Psyros Diagnostics for $7.1M
2022-01-24
Kent, UK-based point-of-care test developer Psyros Diagnostics on Thursday announced it is being acquired by Prolight Diagnostics, based in Lund, Sweden, for SEK 65 million ($7.1 million).
Dell Ventured into Molecular Diagnosis Field
2022-01-21
On January 19, Hangzhou Bioer Technology Co., Ltd. signed a strategic cooperation agreement with Dell.
Total:
3649
Pages:
244
First
Prev
1
..
158
159
160
161
162
163
164
..
244
Next
End